CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 64 filers reported holding CHEMOCENTRYX INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $8,929,000 | +36.3% | 1,102,332 | +1.8% | 0.06% | +30.4% |
| Q3 2015 | $6,552,000 | -29.2% | 1,082,957 | -3.7% | 0.05% | -17.9% |
| Q2 2015 | $9,254,000 | -3.6% | 1,124,397 | -11.6% | 0.06% | +1.8% |
| Q1 2015 | $9,604,000 | +10.1% | 1,272,098 | -0.4% | 0.06% | +7.8% |
| Q4 2014 | $8,721,000 | +41.8% | 1,276,833 | -6.6% | 0.05% | +34.2% |
| Q3 2014 | $6,151,000 | -25.0% | 1,366,793 | -2.4% | 0.04% | -22.4% |
| Q2 2014 | $8,196,000 | -11.8% | 1,400,993 | -0.1% | 0.05% | -12.5% |
| Q1 2014 | $9,297,000 | +2928.3% | 1,402,303 | +6362.2% | 0.06% | +2700.0% |
| Q2 2013 | $307,000 | – | 21,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
| Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
| Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
| HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
| Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
| Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
| Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
| Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
| RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
| Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |